Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Cantuaria, Guilherme	Northside Hospital Atlanta United States	Georgia NCI Community Oncology Research Program (GA NCORP)	3UG1CA189997-11S1	Vanessa A. White, M.P.H.
Cao, Yin	Washington University United States	PROSPECT-Global Consortium and Risk Factor Discovery	3OT2CA297576-01S1	Asad Umar, D.V.M., Ph.D.
Cao, Shugeng	University Of Hawaii At Hilo United States	Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors	5UG3CA290375-02	Altaf Mohammed, Ph.D.
Cao, Yin	Washington University United States	Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia	4R37CA246175-06	Asad Umar, D.V.M., Ph.D.
Cao, Weidan	Ohio State University United States	Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System	1R01CA301579-01	Eileen Dimond, R.N., M.S.
Carlson, Jay W	Ozark Health Ventures, Llc United States	Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO)	3UG1CA189822-11S1	Vanessa A. White, M.P.H.
Carson, Tiffany Lashaun	H. Lee Moffitt Cancer Ctr & Res Inst United States	Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults	5R01CA253219-06	Young Kim, Ph.D.
Castilla, Lucio H.	Univ Of Massachusetts Med Sch Worcester United States	Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD	1U01CA296350-01	Marjorie Perloff, M.D.
Castro, Cesar M	Massachusetts General Hospital United States	Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach	3U01CA279858-03S2	Christos Patriotis, Ph.D., M.Sc.
Caulin, Carlos	University Of Arizona United States	Genetic Alterations That Confer High Risk to Oral Premalignant Lesions	5R01CA274857-04
Caywood, Emi H	Nemours Children'S Hospital, Delaware United States	Nemours NCI Community Oncology Research Program (NCORP)	3UG1CA189958-11S1	Vanessa A. White, M.P.H.
Chak, Amitabh	Case Western Reserve University United States	Pathways of Injury and Repair in Barrett's Carcinogenesis	5P01CA269019-03	Asad Umar, D.V.M., Ph.D.
Chan, Alexandre	University Of California-Irvine United States	Neurotrophic strategy to mitigate chemotherapy-related brain injury	5R01CA276212-03	John Clifford, Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	3OT2CA297680-01S1	Asad Umar, D.V.M., Ph.D.
Chan, Daniel Wanyui	Johns Hopkins University United States	Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions	5U01CA274514-03	Matthew Young, Ph.D.